Serological Detection of SARS-CoV-2 Antibodies in Naturally-Infected Mink and Other Experimentally-Infected Animals.
Animals
Antibodies, Viral
/ blood
COVID-19
/ diagnosis
COVID-19 Serological Testing
Chiroptera
/ immunology
Coronavirus Nucleocapsid Proteins
/ immunology
Epidemiological Monitoring
Ferrets
/ immunology
Immunoprecipitation
Mesocricetus
/ immunology
Mink
/ immunology
Phosphoproteins
/ immunology
Rabbits
/ immunology
SARS-CoV-2
/ immunology
Seroepidemiologic Studies
Spike Glycoprotein, Coronavirus
/ immunology
SARS-CoV-2
animal
luciferase immunoprecipitation systems
mink
nucleocapsid
sera
spike
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
19 08 2021
19 08 2021
Historique:
received:
09
07
2021
revised:
16
08
2021
accepted:
17
08
2021
entrez:
28
8
2021
pubmed:
29
8
2021
medline:
14
9
2021
Statut:
epublish
Résumé
The recent emergence of SARS-CoV-2 in humans from a yet unidentified animal reservoir and the capacity of the virus to naturally infect pets, farmed animals and potentially wild animals has highlighted the need for serological surveillance tools. In this study, the luciferase immunoprecipitation systems (LIPS), employing the spike (S) and nucleocapsid proteins (N) of SARS-CoV-2, was used to examine the suitability of the assay for antibody detection in different animal species. Sera from SARS-CoV-2 naturally-infected mink (
Identifiants
pubmed: 34452513
pii: v13081649
doi: 10.3390/v13081649
pmc: PMC8402807
pii:
doi:
Substances chimiques
Antibodies, Viral
0
Coronavirus Nucleocapsid Proteins
0
Phosphoproteins
0
Spike Glycoprotein, Coronavirus
0
nucleocapsid phosphoprotein, SARS-CoV-2
0
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIDCR NIH HHS
ID : Intramural Research Program
Pays : United States
Organisme : Government of Japan for the IAEA Peaceful Uses Initiative
ID : Project "Detection of emerging and re-emerging animal and zoonotic pathogens at the animal-human interface
Références
Emerg Infect Dis. 2021 Apr;27(4):1015-1022
pubmed: 33770472
J Clin Invest. 2020 Dec 1;130(12):6366-6378
pubmed: 32991329
Transbound Emerg Dis. 2021 Apr 28;:
pubmed: 33909351
Vet Res Commun. 2021 Feb;45(1):1-19
pubmed: 33464439
Euro Surveill. 2020 Jun;25(23):
pubmed: 32553059
BMC Res Notes. 2011 Nov 16;4:498
pubmed: 22087883
Animals (Basel). 2021 May 16;11(5):
pubmed: 34065657
BMJ. 2020 Jul 1;370:m2516
pubmed: 32611558
One Health. 2020 Dec;10:100164
pubmed: 32904469
Transbound Emerg Dis. 2021 Feb 7;:
pubmed: 33550715
J Vet Res. 2021 Mar 09;65(1):1-5
pubmed: 33817389
Eur J Immunol. 2020 Aug;50(8):1234-1236
pubmed: 32584420
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Emerg Infect Dis. 2021 Apr;27(4):1193-1195
pubmed: 33754987
J Infect Dis. 2020 Jun 29;222(2):206-213
pubmed: 32427334
Emerg Infect Dis. 2020 Dec;26(12):2982-2985
pubmed: 33089771
J Virol. 2021 Mar 10;:
pubmed: 33692203
Clin Infect Dis. 2021 May 20;:
pubmed: 34013321
One Health Outlook. 2021 Apr 7;3:7
pubmed: 33834160
PLoS One. 2021 Apr 28;16(4):e0250853
pubmed: 33909706
Lancet Microbe. 2020 Sep;1(5):e218-e225
pubmed: 32838346
Vet Res. 2006 Mar-Apr;37(2):191-200
pubmed: 16472519
J Virol Methods. 2016 Jan;227:40-6
pubmed: 26506137
Nature. 2021 Apr;592(7852):122-127
pubmed: 33636719
Nature. 2020 Jul;583(7818):834-838
pubmed: 32408338
J Virol. 2021 Jan 13;95(3):
pubmed: 33144321
Front Immunol. 2020 Dec 18;11:610688
pubmed: 33391281
EFSA J. 2021 Mar 03;19(3):e06459
pubmed: 33717355
Nat Commun. 2021 Jan 4;12(1):81
pubmed: 33398055
Cell Host Microbe. 2020 May 13;27(5):704-709.e2
pubmed: 32259477
J Clin Virol. 2020 Aug;129:104512
pubmed: 32563180
Transbound Emerg Dis. 2021 Jul;68(4):1779-1785
pubmed: 33191578
EBioMedicine. 2020 Dec;62:103101
pubmed: 33160207
Trends Microbiol. 2017 Jan;25(1):35-48
pubmed: 27743750